Karyopharm Therapeutics Inc. KPTI
1.62
(0.11)
(6.36%)
as of 25 Sep
- Market cap
- $39.2M
- P/E
- 0.0×
Follow KPTI
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.55 | 0.57 | 0.71 | 1.70 | 2.31 | 10.32 | 29.06 | 17.55 | 275.76 | 2,021.82 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(6.80) | (3.19) | (5.54) | (9.95) | 18.99 | (36.42) | (30.09) | (11.05) | (82.26) | (18.10) |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.07 | 23.87 | 2.91 | 3.52 | 2.23 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.07 | 23.87 | 2.91 | 3.52 | 2.23 |
EV/Sales |
1.67 | 1.11 | 0.58 | 1.02 | 2.00 | 9.10 | 25.35 | 10.11 | 186.97 | 1,298.06 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(3.23) | (1.26) | (0.92) | (1.08) | (3.93) | (6.14) | (5.43) | (1.93) | (4.19) | (2.75) |
EV/FCF |
(3.23) | (1.26) | (0.92) | (1.08) | (3.91) | (6.13) | (5.43) | (1.90) | (4.19) | (2.75) |
Quick Ratio |
0.98 | 1.51 | 3.15 | 4.95 | 3.49 | 4.40 | 5.85 | 7.00 | 2.97 | 7.86 |
Current Ratio |
1.12 | 1.70 | 3.37 | 5.31 | 3.74 | 4.59 | 6.01 | 7.13 | 3.00 | 7.99 |
Net Debt/EBITDA |
(2.03) | (0.68) | 0.16 | 0.75 | 0.67 | 0.82 | 0.83 | 1.27 | 1.14 | 1.19 |
Debt/Assets |
209.28% | 113.96% | 71.09% | 48.29% | 56.21% | 38.28% | 37.80% | 30.09% | 0.00% | 0.00% |
Debt/Equity |
(0.77) | (1.01) | (1.25) | (10.39) | (2.15) | 2.37 | 2.24 | 0.56 | 0.00 | 0.00 |
Asset Turnover |
1.07 | 0.72 | 0.49 | 0.47 | 0.68 | 0.36 | 0.13 | 0.12 | 0.01 | 0.00 |
Operating CF/Net income |
0.38 | 1.67 | 0.65 | 0.90 | 0.86 | 0.82 | 0.96 | 0.89 | 0.57 | 0.77 |
Capex/Depreciation |
0.00 | (0.03) | 0.00 | (0.19) | (0.07) | (0.01) | (0.03) | (1.08) | (0.03) | (0.04) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 81.86% | 47.43% | 187.23% | 343.18% | 852.05% | (391.29%) | (171.36%) | (114.13%) | (88.43%) | (60.77%) | |
| (143.71%) | (37.75%) | (47.81%) | (49.83%) | (40.13%) | (64.56%) | (62.75%) | (68.42%) | (71.52%) | (55.37%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (211.70%) |
Return on Tangible Assets |
(1,751.91%) | (118.30%) | (86.70%) | (57.92%) | (60.97%) | (89.81%) | (84.84%) | (61.19%) | (127.53%) | (92.87%) |
Average Days of Receivables |
65.42 | 77.32 | 67.39 | 109.42 | 39.14 | 43.50 | 70.17 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
86.00% | 98.62% | 95.01% | 94.64% | 76.66% | 139.53% | 299.17% | 531.95% | 6,683.68% | 56,453.25% |
Selling, General and Administrative Expense of Revenue |
72.03% | 79.48% | 90.31% | 92.57% | 68.56% | 116.96% | 257.80% | 161.02% | 1,549.53% | 15,550.65% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
9.62% | 12.69% | 14.87% | 22.54% | 14.19% | 22.58% | 37.39% | 56.95% | 1,271.34% | 14,469.48% |
Graham Net Nets |
(3.71) | (2.35) | (1.39) | (0.09) | (0.23) | 0.01 | 0.03 | 0.33 | 0.21 | 0.31 |
Graham Number |
103.94 | 71.93 | 86.84 | 45.70 | 94.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(243.54%) | (99.06%) | (138.61%) | (62.24%) | (25.80%) | (17.63%) | (16.84%) | (33.39%) | (28.21%) | (30.38%) |
Free Cash Flow Yield |
(93.82%) | (154.91%) | (90.16%) | (56.05%) | (22.20%) | (14.37%) | (16.08%) | (30.34%) | (16.20%) | (23.34%) |
Revenue per Share |
13.36 | 17.88 | 19.17 | 28.76 | 41.82 | 22.49 | 9.90 | 8.01 | 0.52 | 0.06 |
Operating CF per Share |
(6.89) | (15.69) | (12.17) | (27.39) | (21.35) | (33.35) | (46.18) | (42.01) | (24.08) | (33.72) |
Capex per Share |
0.00 | (0.02) | 0.00 | (0.02) | (0.04) | (0.03) | (0.05) | (0.62) | (0.02) | (0.03) |
Free Cash Flow per Share |
(6.89) | (15.71) | (12.17) | (27.41) | (21.39) | (33.38) | (46.23) | (42.64) | (24.10) | (33.75) |
Cash per Share |
5.83 | 13.38 | 25.22 | 51.10 | 46.83 | 52.38 | 63.66 | 86.66 | 47.91 | 51.76 |
Shareholders Equity per Share |
(26.79) | (22.89) | (17.88) | (3.05) | (15.88) | 10.52 | 12.04 | 48.37 | 42.29 | 64.82 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(26.79) | (22.89) | (17.88) | (3.05) | (15.88) | 10.52 | 12.04 | 48.37 | 42.29 | 64.82 |
Free Cash Flow |
(75.37) | (127.63) | (92.72) | (149.67) | (107.33) | (160.38) | (191.03) | (161.48) | (73.78) | (84.46) |
Working Capital |
11.09 | 64.20 | 164.44 | 284.25 | 201.89 | 216.33 | 232.22 | 287.71 | 98.96 | 115.16 |
Capital Expenditures |
— | (0.14) | — | (0.12) | (0.21) | (0.14) | (0.21) | (2.36) | (0.06) | (0.07) |
Net Current Asset Value |
(298.20) | (193.97) | (142.72) | (24.67) | (109.37) | 14.03 | 33.38 | 176.59 | 97.59 | 113.49 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.08 | 0.04 | 0.45 |
Net Profit Margin |
(134.21%) | (52.62%) | (97.99%) | (105.23%) | (59.14%) | (181.59%) | (488.08%) | (588.10%) | (8,036.39%) | (71,153.90%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
100.31 | 10.51 | (4.54) | 0.53 | 1.91 | 4.71 | 2.23 | 0.57 | 0.87 | 0.68 |
Cash ROIC |
3,300.09% | (116.19%) | (41.15%) | (34.61%) | (33.27%) | (38.49%) | (45.69%) | (26.54%) | (27.49%) | (29.89%) |
Accounts Receivable Turnover |
5.13 | 5.03 | 3.94 | 4.51 | 11.86 | 10.42 | 3.94 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
1.31 | 1.46 | 1.68 | 2.38 | 1.12 | 1.00 | 0.91 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
1.36 | 1.54 | 1.36 | 1.25 | 1.01 | 1.81 | 1.61 | — | — | — |
Average Days of Payables |
245.60 | 310.31 | 230.65 | 194.16 | 171.99 | 600.46 | 149.37 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
247.75 | 287.95 | 224.75 | 295.75 | 440.53 | 356.77 | 52.47 | — | — | — |
Average Receivables |
28.47 | 28.86 | 37.02 | 34.79 | 17.69 | 10.37 | 10.37 | — | — | — |
Average Payables |
4.56 | 4.12 | 2.95 | 2.19 | 3.03 | 2.72 | 2.66 | 5.00 | 5.21 | 4.28 |
Average Inventory |
4.39 | 3.89 | 3.63 | 4.17 | 3.38 | 1.50 | 1.50 | — | — | — |
Average Assets |
136.42 | 202.43 | 299.31 | 331.74 | 309.18 | 304.01 | 318.08 | 260.74 | 180.34 | 197.91 |
Average Common Equity |
(239.47) | (161.11) | (76.43) | (48.16) | (14.56) | 50.16 | 116.47 | 156.32 | 145.85 | 180.30 |
Columns are period end dates